Neuman John 4

What Happened John Neuman, a director of SeaStar Medical Holding Corp. (ICU), received an award of 3,000 restricted stock units (RSUs) on February 6, 2026. The Form 4 reports the acquisition price as $0.00 (total reported value $0), indicating these RSUs were granted as compensation rather than bought. The RSUs will vest in full on February 6, 2027 per the filing footnote.

Key Details

• Transaction date: 2026-02-06; Filing date: 2026-02-10 (filed after the transaction date).
• Award: 3,000 RSUs granted at $0.00 each (reported total $0).
• Vesting: RSUs vest in full on 2027-02-06 (Footnote F1).
• Shares owned after transaction: not disclosed in this Form 4.
• Remarks/Exhibits: Ex. 24.1 — Power of Attorney included.
• Timeliness: The Form 4 was filed four days after the transaction date (insider reports are normally due within two business days), so this filing appears late.

Context RSUs are a form of compensation that convert to actual shares upon vesting and may be forfeitable until that time; they are not an open-market purchase or sale. Such grants to directors are common and reflect compensation practices rather than an immediate buy/sell signal. The late filing affects reporting timeliness but does not by itself indicate trading intent.